Net profit of Novelix Pharmaceuticals rose 307.69% to Rs 0.53 crore in the quarter ended September 2025 as against Rs 0.13 crore during the previous quarter ended September 2024. Sales rose 818.18% to Rs 36.36 crore in the quarter ended September 2025 as against Rs 3.96 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 36.36 | 3.96 | 818 |
| OPM % | 1.93 | 5.30 | - |
| PBDT | 0.73 | 0.13 | 462 |
| PBT | 0.72 | 0.13 | 454 |
| NP | 0.53 | 0.13 | 308 |